Blink Charging Co. BLNK Change In Fair Value Of Derivative And Other Accrued Liabilities

Change In Fair Value Of Derivative And Other Accrued Liabilities at other companies

Gyre Therapeutics, Inc.GYRE

$39K-32.8%

BiohavenBHVN

$0+100%

Solid Biosciences Inc.SLDB

-$1.65M0.0%

Grove Collaborative HoldingsGROV

-$99K+31.3%

KLR

Kalaris Therapeutics, Inc. Common StockKLRS

$0-100%

KLR

Kalaris Therapeutics, Inc. Common StockKLRS

$0-100%

Other financials

Income statement

See full

Revenue$20.8M+0.3%

Gross profit$6.6M-6.1%

Operating income-$11.8M+44.9%

Net income-$11.6M+45.0%

EPS (diluted)-$0.08+61.9%

Balance sheet

See full

Cash & equivalents$38.0M-9.8%

Total debt$7.2M-29.0%

Total equity$54.0M-47.2%

Total assets$133.2M-33.1%

Cash flow

See full

Operating cash flow$671.0K+105%

CapEx$1.6M+50.1%

Free cash flow-$961.0K+93.2%

Valuation

See full

Market cap$91.93M-11.4%

Enterprise value$61.11M-30.3%

P/S0.9×-0.1×

Profitability

See full

Gross margin24.2%-6.4pp

Operating margin-71.9%-27.5pp

Net margin-71.4%-27.3pp

FCF margin-42.7%-11.2pp

Returns & leverage

See full

Return on equity-94.6%-7.0pp

Debt / equity0.1×0.0×

Current ratio1.2×-0.9×

Where this comes from

Reported directly by Blink Charging Co. in its filing.

Tagged under the XBRL concept BLNK:ChangeInFairValueOfDerivativeAndOtherAccruedLiabilities.

The official record: Blink Charging Co.’s 10-K, filed March 31, 2026, on SEC EDGAR. View the filing →

Ask your AI about Blink Charging Co.'s change in fair value of derivative and other accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Blink Charging Co.'s change in fair value of derivative and other accrued liabilities?: Blink Charging Co. (BLNK) reported change in fair value of derivative and other accrued liabilities of $0 in Q4 2025.
What does change in fair value of derivative and other accrued liabilities mean?: Represents the non-cash impact of market-driven fluctuations in the valuation of derivative instruments and specific accrued liabilities. This metric helps isolate the impact of financial market volatility on the company's operating results.